Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
511 Davis Drive, Suite 100, Morrisville, NC, 27560, US
When initiating a development program for drug delivery to the lungs, selection of the dosage form warrants careful consideration.
Released By Kemwell Biopharma
This demonstrates the company’s ability to meet cGMP and aseptic drug-product manufacturing standards.
By: Rachel Klemovitch
A look at the shifting strategies and surging sectors reshaping the Top 20 drugmakers.
By: Tim Wright
Dr. Barker is an experienced clinical immunologist with broad executive experience across both big pharma and biotech.
By: Charlie Sternberg
Strategies to ensure accessibility and affordability of innovations globally.
By: Soman Harachand
Where big pharma stands in the face of nimble tech-driven start-ups, the impact of layoffs, and what we can expect from M&A in the future.
By: Kristin Brooks
Collaboration leverages Kemwell's manufacturing excellence and RevOpsis' Rev-Mod platform to expedite the development of novel multispecific biologics.
Aims to drive quality excellence across its development and manufacturing operations with the cloud-based platform.
Aims to expedite development, manufacturing, licensing, import and export of cell therapy products.
By: Anthony Vecchione
Brings 20 years of big pharma and biotech infectious disease clinical trial experience.
Offshoring to support drug development.
Ms. Baranowski brings more than two decades of experience leading a vast array of functions in biotech, big pharma and venture capital firms.
USFDA 505(b)(2) pathway submissions (“(b)(2)s”) can be advantageous because they offer the potential for the accelerated approval of patient-centric medicines.
Inks deal with top 10 big pharma and will provide manufacturing support from facility in Kaysersberg, France.
Partnership to focus on developing, manufacturing and commercializing biosimilars.
Paves the way towards getting OCU200 in the clinic by first half of 2022.
By: Contract Pharma
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
